In this context, the first analysis of PTEN/PI3K/AKT/mTOR pathway activation in patient specimens was carried out on 45 untreated primary GBM; immunohistochemistry analysis revealed that PTEN loss correlated with AKT activation and that in turn AKT phosphorylation significantly correlated with mTOR, FOXO1, FOXO3a, FOXO4, and S6 activation [43]. This evidence concerns the gene AKT1 and glioblastoma.